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 Abstract 
 Lasers are routinely used in veterinary ophthalmology for 
the treatment of a number of ophthalmic conditions and dis-
eases. In veterinary ophthalmology, gas lasers (CO 2 lasers) 
and semiconductor lasers (diode lasers) are used primarily, 
but the therapy of posterior capsular opacifi cation with the 
Nd:YAG laser has also been described. This paper presents 
and discusses the most common indications for the use of 
the diode and CO 2 lasers. Diode lasers are mainly used in 
the treatment of glaucoma, either by transscleral cyclopho-
tocoagulation or by endoscopic cyclophotocoagulation. 
Other indications are various forms of retinal detachments, 
as well as pigmented neoplasms of the uvea. An emerging 
fi eld in veterinary ophthalmology using diode lasers is pho-
todynamic therapy of periocular tumors. CO 2 lasers are used 
for pars plana vitrectomies and surgical excision of ocular 
tumors.
 Keywords:  diode laser;  carbon dioxide laser;  ophthalmic 
surgery;  animal .
 Zusammenfassung 
 Laser werden in der Veterin ä r-Ophthalmologie zur Behand-
lung unterschiedlicher Augenver ä nderungen und -erkrankun-
gen regelm ä ß ig eingesetzt. Es kommen haupts ä chlich Gas 
(CO 2 )- und Halbleiterlaser (Diodenlaser) zur Anwendung, aber 
auch der Nd:YAG-Laser wird eingesetzt, bspw. zur Therapie 
des Nachstars (posterior capsular opacifi cation, PCO). Im 
vorliegenden Artikel werden die h ä ufi gsten Indikationen zur 
Verwendung von Dioden- und CO 2 -Lasern vorgestellt und 
diskutiert. Diodenlaser werden haupts ä chlich zur Therapie 
des Glaukoms eingesetzt, sei es mittels transskleraler oder 
mittels endoskopischer Zyklophotokoagulation. Andere 
Indikationen sind verschiedene Formen der Netzhautabl ö sung 
sowie pigmentierte Tumoren der Uvea. Ein neu aufkommen-
des Einsatzgebiet f ü r Diodenlaser ist die photodynamische 
Therapie von periokul ä ren Tumoren. CO 2 -Laser werden in 
erster Linie f ü r die Pars-plana-Vitrektomie beim Pferd und 
zur Exzision von Tumoren verwendet. 
 Schl ü sselw ö rter:  Diodenlaser;  CO2-Laser;  Augenchirurgie; 
 Tier. 
 1. Introduction 
 While lasers have been employed in human ophthalmol-
ogy since the 1970s  [1, 2] and have a wide fi eld of applica-
tions  [3 – 9] , the earlier laser units, such as argon, krypton 
and the fi rst Nd:YAG lasers were not really suitable for use 
in veterinary medicine because they were large and heavy 
units requiring an elaborate cooling system. The advent of 
the portable semiconductor (diode) lasers has made laser 
surgery both feasible and affordable for veterinary use  [10, 
11] . In veterinary ophthalmology lasers are mainly used to 
treat various forms of glaucoma, retinal detachments, and 
pigmented ocular tumors. Therapy of posterior capsular 
opacifi cation (PCO) with Nd:YAG lasers have also been 
described  [12] . 
 This paper presents and discusses the most common indica-
tions for the use of diode and CO 2 lasers including the emerg-
ing fi eld of photodynamic therapy of periocular tumors. 
 2. Semiconductor (diode) lasers 
 Presumably the most common laser used in veterinary oph-
thalmology is the diode laser emitting light at a wavelength of 
810 nm  [11] . As a semiconductor laser, the unit is lightweight 
and therefore transportable and does not require extensive 
cooling systems. The laser light is delivered through an opti-
cal fi ber directly to the required tissue  [9] . The most com-
monly used diode laser (DioVet  ®  ; IRIS Medical Employment, 
Den Haag, The Netherlands) emits laser light at 810 nm 
thereby targeting pigmented tissues. The maximum energy 
is 2000 mW, and an exposure duration of up to 9000 ms 
(Figure  1 )  [13] . 
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 2.1. Transscleral laser cyclophotocoagulation 
 Diode lasers are routinely used to treat various forms of pri-
mary glaucoma in dogs, cats and horses  [11, 14 – 18] . 
 The goal is to partially destroy the non-pigmented cili-
ary epithelium, to reduce aqueous humor secretion, and 
thus decrease intraocular pressure (IOP). The laser energy 
delivered is captured by the neighboring pigmented ciliary 
epithelium, and the resulting thermal effects also affect the 
non-pigmented epithelium. 
 In small animals, the laser probe is positioned perpendic-
ular to the sclera and 3 mm posterior to the limbus (dorsal 
hemisphere), or 4 mm posterior to the limbus (ventral hemi-
sphere). In horses the probe is positioned 4 – 6 mm posterior to 
the limbus (Figure  2 )  [16, 19, 20] . 
 The 3 o ’ clock and 9 o ’ clock positions and the posterior 
ciliary arteries are avoided  [11] . The original settings were 
1500 mW and 1500 ms for 36 spots. This energy level should 
cause a popping sound (photodisruption) in about 20 % of 
the spots, indicating an effective level of energy. However, 
photodisruption caused considerable postoperative uveitis, 
and consequently the settings were changed to 1000 mW and 
3 – 5000 ms. 
 Photocoagulation, not photodisruption, is achieved with 
these settings  [21] . Some surgeons treat only a small number 
of spots at a given time and repeat the treatment as needed to 
titrate IOP to the target pressure of  < 20 mm Hg. 
 One of the pitfalls of transscleral laser photocoagulation 
is post-operative pressure spikes, which have to be carefully 
monitored and treated. 
 Other methods of cyclophotodestruction/-ablation include 
cyclocryotherapy. This is an established method in glauco-
mas that are non-responsive to medical therapy. The expected 
destruction was rather unpredictable and sometimes short-
lived. A serious complication of this treatment was the occur-
rence of retinal detachments  [22] . 
 2.2. Endocyclophotocoagulation 
 In recent years endoscopic laser cyclophotocoagulation 
 [23] has been advocated but controlled studies of its long-
term usefulness in animals are as yet lacking. This procedure 
involves the introduction of a diode laser probe and the trans-
mission of laser light into the anterior chamber. The ciliary 
sulcus is extended with viscoelastic substances and the probe 
is advanced toward the ciliary processes. The ciliary epithe-
lium is laser-treated in a controlled fashion over 270–360 
degrees of the pars pilcata. Since cataract formation is a fre-
quent complication of endolaser surgery, the procedure is best 
performed on aphakic or pseudophakic patients  [24, 25] . 
 2.3. Transscleral laser retinopexy 
 Retinal detachments, so-called giant tears, are frequent com-
plications of intracapsular extraction of luxated lenses in dogs 
and cats, but they can also occur spontaneously. The retinal 
disinsertions at the level of the ora ciliaris retinae can be 
avoided by prophylactic transscleral retinopexy  [26] . In cer-
tain breeds of dogs, rhegmatogenous retinal detachments are 
frequent complications after extracapsular cataract surgery 
and these can also be prevented by transscleral retinopexy. 
In general, 4–5 rows of spots are applied beginning 10 mm 
posterior to the limbus with a total of 65–75 spots. The rec-
ommended settings are 800 mW and 1000 ms  [26] . 
 Cryopexy of detached retinas has been used in canine vit-
reoretinal surgery  [27] , but has largely been replaced by laser 
retinopexy. The delivery of thermal energy to actively seal the 
retina to the underlying RPE appears to be more precise and 
effective with laser treatment. 
 2.4. Transpupillary laser retinopexy 
 Occasionally circumscribed bullous retinal detachments or 
localized retinal tears are encountered in animals. Usually 
these are incidental fi ndings since such localized lesions 
rarely lead to recognizable visual defi cits. 
 If these lesions are not located in the far periphery of the 
ocular fundus, they are amenable to treatment via an indirect 
diode laser ophthalmoscope (Figure  3 ). For optimal posi-
tioning and immobilization of the globe, the patient is anes-
thetized and the pupil maximally dilated. With the indirect 
ophthalmoscope and a 20 diopter condensing lens, the laser 
beam is focused on the exact retinal spots to be treated  [28] . 
The spot size at the level of the ophthalmoscope is usually 0.4 
mm and the focal length 35.6 cm  [29] . Settings vary between 
 Figure 1  Front panel of the diode laser DioVet  ®  (IRIS Medical 
Employment, Den Haag, The Netherlands). 
 Figure 2  Glaucoma probe for transscleral cyclophotocoagulation. 
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100 and 200 mW and 100 and 600 ms, based on the observed 
effect. Less energy is required in the nontapetal fundus com-
pared to the tapetal area. In the nontapetal fundus laser burns 
are immediately recognized as whitish spots, while in the 
tapetum the spots have a bronze-like color (Figure  4 A,B). 
The result is a focal coagulation necrosis effectively sealing 
the retina to the underlying pigmented epithelium  [28] . Large 
retinal vessels should be avoided to prevent hemorrhage. The 
laser spots are placed next to one another to prevent liquefi ed 
vitreous entering between neuroretina and pigmented epithe-
lium, thus limiting the retinal detachment or tear to the imme-
diate area  [28] . 
 2.5. Iris melanoma (choroidal melanoma) 
 The diagnosis of iridal melanoma is based on the following 
parameters: (1) dark brown pigmented lesion, (2) loss of nor-
mal texture of the superfi cial iridal stroma, (3) thickened and 
velvety lesion, (4) dyscoria and inhibition of normal pupil 
mobility, and (5) gonioscopic involvement of drainage angle 
structures  [30] . Fine needle aspirations of uveal tumors may 
confi rm the clinical diagnosis, although the small number of 
cells and the heavy pigmentation encountered in most cases 
render cytopathology diffi cult  [31] . 
 Iridal melanomas are the most common primary intraocular 
tumors in dogs and cats (Figure  5 ). They are locally invasive 
and may lead to hemorrhage and secondary glaucoma  [32 –
 34] . They may also metastasize to different locations  [34 – 36] . 
If diagnosed early, they can be successfully treated. Tumors 
limited to the iris stroma without involvement of the drainage 
angle carry a favorable diagnosis. Flat lesions are preferable 
because of the limited penetration of laser energy. The thick-
ness of such lesions can be measured using high resolution 
ultrasound ( ≥ 20 mHz)  [37] . 
 The special adapter for the operating microscope allows 
delivery of laser energy through the cornea by aid of a joy-
stick without any collateral damage at the level of the cornea 
(Figure  6 )  [38] . The spot size is 0.3 mm and the energy level 
is between 100 mW and 1000 mW depending on the observed 
effect. In continuous mode, the tissue effect can be monitored 
directly (Figure  7 ). Desirable effects are obvious shrinking of 
the tissue and as a consequence, a deformation of the pupil. 
Photodisruption with dispersion of pigmented tissue should 
be avoided by carefully adjusting the energy level  [29] . 
 Preoperatively, the pupil is kept miotic with 1 % pilocarpine 
drops. At the end of the treatment, the pupil should be dilated 
with 1 % atropine sulfate and the eye should be treated with 
anti-infl ammatory eye drops. Laser treatment of suspected 
uveal melanomas may have to be repeated after several weeks, 
especially in tumors with an average thickness of  > 2 mm. 
 Choroidal melanomas are diagnosed infrequently in 
domestic animals (Figure  8 )  [39 – 43] . Laser therapy of chor-
oidal melanomas has not been described in animals. It could 
potentially be treated in a fashion similar to transpupillary 
laser retinopexy. 
 For small circumscribed neoplasms of the iris, laser therapy 
is less invasive and technically less demanding compared with 
sector iridectomies. For the rare choroidal melanomas, laser 
therapy offers a potentially effective and feasible treatment 
 Figure 3  Indirect diode laser ophthalmoscope (DioVet  ®  ; IRIS 
Medical Employment, Den Haag, The Netherlands). 
A B
 Figure 4  (A) Bullous retinal detachment in a dog prior to barrier retinopexy. (B) The same lesion immediately after laser retinopexy. Note 
the whitish spots. 
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 Figure 8  Choroidal melanoma in a dog (incidental fi nding). 
 Figure 6  DioVet  ®  with operating microscope attachment for the 
Leica operating microscope. 
 Figure 7  Intraoperative image of an uveal melanoma treated with 
the DioVet  ®  (settings: 400 mW, 300 ms). The focused red dot is on 
the tumor, the lighter spot is the refl ection from the cornea. 
 Figure 5  Uveal (iridal) melanoma in a dog. 
option. In people, proton radiation is the treatment of choice 
for similar tumors  [44] . 
 2.6. Epibulbar (limbal melanoma) 
 Limbal or epibulbar melanomas occur more often in dogs 
than in cats  [45 – 49] . They originate from the outer pig-
mented band of the limbus and manifest as darkly pigmented 
masses riding on the limbus and extending into the cornea 
(Figure  9 )  [50] . Gonioscopy shows no involvement of the 
adjacent angular structures. 
 Traditionally they have been treated by keratectomy/sclerec-
tomy  [47, 48] . Surgical removal of limbal melanomas can be 
followed by cryotherapy of remaining neoplastic cells. Surgical 
debulking of limbal melanomas, followed by diode laser pho-
tocoagulation, has been described  [51] . However, this leads to 
superfi cial carbonization of tissue, and in the author ’ s opinion, 
cryotherapy is superior to laser photocoagulation  [13] . 
 2.7. Uveal cysts 
 Uveal cysts are common in dogs, with a breed predilection for 
Golden Retrievers, Labrador Retrievers and Boston Terriers 
 [52] . They are present as round, fl uid fi lled structures of variable 
size with a thin pigmented and often translucent wall (Figure 
 10 ). They arise from the iris, the ciliary body or are found free-
fl oating in the anterior chamber (Figure  11 ). Defl ation with 
a diode laser of such cysts has been described in dogs, cats, 
and horses  [53, 54] . While there have been no adverse effects 
reported with this treatment modality, the cyst wall will remain 
within the anterior chamber and often collapses against the cor-
neal endothelium  [54, 55] . It may not be possible to defl ate 
poorly pigmented uveal cysts with a semiconductor laser  [56] . 
Iris cysts can also be easily removed from the anterior chamber 
by aspiration with a small gauge needle  [57] . 
 2.8. Distichiasis 
 Distichiasis is a common ocular disorder in dogs, but appears 
to be rare in other domestic animals (Figure  12 )  [58, 59] . 
Initially, distichiasis has been managed by partial tarsal 
plate removal  [60] . However, this caused frequent distortion 
and scarring of the lid margin and was later abandoned and 
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 Figure 9  Epibulbal (limbal) melanoma in a dog. 
 Figure 11  Large uveal cyst in a dog obstructing the pupil. The cyst 
is in the process of being removed by aspiration. 
 Figure 10  Free-fl oating uveal cyst in the anterior chamber (AC) of 
a dog. The cyst has gravitated to the bottom of the AC. 
 Figure 12  Distichiasis in a dog. Note that several distichiae may 
emanate from one Meibomian gland opening. 
replaced by cryotherapy  [61, 62] . With this method a destruc-
tion of the hair follicle was achieved with minimal damage to 
the surrounding tissue. The same can be achieved using laser 
photocoagulation  [63] . As yet this has not been reported in 
veterinary ophthalmology. 
 2.9. Photodynamic therapy of periocular squamous 
cell carcinoma 
 A relatively new use of semiconductor lasers is photodynamic 
therapy for the treatment of periocular squamous cell carci-
noma (SCC). The fi rst reports have been promising  [64, 65] . 
 The tumors were surgically resected and the resulting 
wound beds were infi ltrated with 2-[1-hexyloxyethyl]-2-
devinylpyropheophorbide-a. The wounds were then irradi-
ated with a 665 nm diode laser. Usually a single therapeutic 
cycle is necessary to achieve remission of the tumors. 
 3. Gas lasers (carbon dioxide lasers) 
 Carbon dioxide (CO 2 ) lasers are widely used in soft tissue sur-
gery  [66 – 70] and are also used in ocular surgery  [13, 71, 72] . 
 3.1. Sclerotomies for pars plana vitrectomies 
 As CO 2 lasers allow precise cutting of tissue and provide 
hemostasis at the same time, they have been widely used for 
sclerotomies to gain access to the vitreous cavity in pars plana 
vitrectomy in horses  [73 – 78] . A fi rst sclerotomy is performed 
10 mm posterior to the limbus and slightly dilated with a lac-
rimal dilator if needed. The irrigation port is introduced in 
this opening and sutured to the sclera. The second sclerotomy 
is done in a similar fashion to accommodate the vitrectomy 
probe (Figure  13 ), which is carefully introduced and advanced 
towards the center of the vitreal cavity  [78] . 
 3.2. Adnexal tumors 
 The CO 2 laser can also be used to excise focal SCC from the 
eyelids or nictitating membranes of horses (Figures  14 and 
 15 ). The same can be said for periocular sarcoids  [64, 79] . 
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 Figure 15  Excision of a circumscribed squamous cell carcinoma 
by use of the CO 2 laser. 
 Figure 13  CO 2 laser sclerotomy during a pars plana vitrectomy in a 
horse. The irrigation port (left) has already been installed. 
 Figure 14  Squamous cell carcinoma of the third eyelid in a horse. 
 The lowest effective energy levels should be used in order 
to avoid excessive carbonization of surrounding tissue. 
Usually several sweeps are necessary to separate tissues. 
 4. Nd:YAG laser 
 Posterior capsular opacifi cation (PCO) is a frequent complica-
tion of cataract surgery in animals and people. With improved 
surgical technique, the use of viscoelastic materials, and new 
designs of intraocular lenses (IOL), the incidence of PCO 
has been reduced. However, it still occurs and is potentially 
blinding. With the Nd:YAG, laser holes can be opened in the 
opacifi ed lens capsule without the need to reopen the eye. The 
laser energy can be delivered through the clear cornea and the 
IOL. The canine posterior lens capsule is less elastic than that 
of the human eye and does n o t retract as easily. Consequently 
the success rate is lower than in humans. In a series of 33 
dogs the success rate, as assessed by increased clarity of the 
lens capsule, was 75 % . The average canine PCO requires 75 
bursts of 40 mJ each to open the capsule, while in humans 
only 8–10 bursts of 1–2 mJ are necessary  [12, 80] . 
 5. Conclusion 
 Medical lasers have many uses in human and veterinary med-
icine and surgery. Laser technology has evolved over time 
and new concepts and units have emerged. The future will 
see an increase in the lasers used in veterinary ophthalmology 
and the number of diseases and conditions amenable to this 
treatment modality. 
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